Search criteria | ||||
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety. | ||||
Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13 | ||||
1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium. | ||||
Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13. |
||||
, Article | ||||
, Belgium, Germany, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods | 2021 | English | , Patient questionnaire, Review | |
Infections in patients with multiple sclerosis: A national cohort study in Sweden | ||||
Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery | ||||
1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA | ||||
Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23]. |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32736217/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods | 2020 | English | , Epidemiological study | |
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden | ||||
Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery | ||||
1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA | ||||
Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14 |
||||
, Article | ||||
, Sweden | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32864156/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods | 2020 | English | , Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis | |
Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark | ||||
Maja Laursen 1, Christine E Hallgreen 2 3, Nancy Dreyer 4, Alison Bourke 5, Shahrul Mt-Isa 2 6, Stella Blackburn 5 | ||||
1The Danish Health Data Authority, Copenhagen, Denmark. 2School of Public Health, Imperial College London, London, UK. 3Copenhagen Center for Regulatory Science, Department of Pharmacy, SUND, University of Copenhagen, Copenhagen, Denmark. 4IQVIA Real-World and Analytic Solutions, Boston, Massachusetts. 5IQVIA Real-World and Analytic Solutions, London, UK. 6Biostatistics and Research Decision Sciences, MSD Research Laboratories, London, UK. | ||||
Pharmacoepidemiol Drug Saf . 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6. |
||||
, Article | ||||
, Denmark, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31811680/ | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Pregnancy | 2020 | English | , Epidemiological study, Methodology, Patient questionnaire, Real World Data | |
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Menopause |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29994974 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Int Urogynecol J |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29946829 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
EPIDEMIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDERS IN SPAIN BASED ON REAL-WORLD DATA | ||||
Ramos-Quiroga JA (1), Targhetta M (2), Gasche D (2), Rubio M (2), Perulero N (3) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain; 3IQVIA Information, Barcelona, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN | ||||
Ramos-Quiroga JA (1), Tang JP (2), Solozabal M (2), De Prado A (2), Miñarro C (2), Callejo-Velasco D (2) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
The Prevalence of Multimorbidity and Polypharmacy in Elderly Patients Followed in General Practices in Germany | ||||
Kostev K, Kap EJ, Jacob L | ||||
IQVIA, Frankfurt am Main, Germany, University of Paris 5, Paris, France | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2018 | English | , Epidemiological study, Retrospective database analysis | |
Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010–2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G. | ||||
Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire | ||||
2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare Diseases | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective database analysis | |
Treatment Patterns, Adherence, and Persistence among Psoriasis Patients Treated with Biologics in a Real-World Setting, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: cBrigham and Women’s | ||||
Journal of Dermatological Treatment |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/09546634.2018.1479725?journalCode=ijdt20 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Healthcare Resource Utilization and Costs among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: Harvard Medical School; Araujo AB: Eli Lilly and Company | ||||
Journal of Medical Economics |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1080/13696998.2018.1472097 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Patient Registries & Real-World Study Methods, Pricing and reimbursement | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Database Analysis of Venous Thromboembolism Treatment Patterns in Inpatients vs Outpatient Settings | ||||
Woodcroft KJ, Phillips S, Maranzano G, Caberwal H | ||||
Woodcroft KJ: Henry Ford Health System; Phillips S: IQVIA; Maranzano G: Boehringer Ingelheim Pharmaceuticals; Caberwal H: Boehringer Ingelheim Pharmaceuticals | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe | ||||
Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA | ||||
Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Denmark, Finland, Germany, Norway, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review | |
Developing a Multiphase Claims-Based Algorithm for Non-Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis. | ||||
Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7 | ||||
1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden | ||||
ISPOR 20th Annual European Congress |
||||
, Germany, Nordic, Sweden | ||||
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology | 2017 | English | , Retrospective database analysis | |
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record (AEMR) Data: Duchenne Muscular Dystrophy (DMD) | ||||
Anderson A1, Casso D1, Susan A. Oliveria SA 1, Douglas Kou T 2 | ||||
1 QuintilesIMS ,2 BMS | ||||
33rd International Conference on Pharmacoepidemiology & Thereputic Risk Management; August, 28, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Musculoskeletal disease, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Measuring Breast Cancer Screening Rates in a US Administrative Claims Database | ||||
Karin E. Johnson, Stacey Fedewa, Dawn Wiatrek, Jennifer Lomardo, Melissa Pirolli, Susan A. Oliveria | ||||
QuintilesIMS | ||||
33rd International Conference on Pharmacoepidemioligy, Montreal, Canada; August 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record Data: Progressive Supranuclear Palsy | ||||
Anderson A, Casso D, Oliveria SA, Kou TD | ||||
AA, DC, and SAO are employees of QuintilesIMS. TDK is an employee of BMS | ||||
33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26-30, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Demographic Characteristics and Treatment Patterns Among Patients Treated for Hereditary Angioedema in a US Cohort, 2006-2015 | ||||
Raffi Tachdjian, Karin E. Johnson, Deborah Casso1, Susan A. Oliveria1, Giovanna Devercelli2, Gagan Jain2 | ||||
1, QuintilesIMS ; 2, Shire Development LLC | ||||
North American Rhinology & Allergy Conference, February 9–11, 2017, Puerto Rico |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Can Valid Cases of Schizophrenia Be Identified in Administrative Claims Data? | ||||
Syd Phillips, Matthew Sidovar, Deb Casso, Jeremiah J. Trudeau, Kimberley J. Woodcroft, Susan A. Oliveria | ||||
P, DC, and SAO QuintilesIMS. MT, JT Boehringer Pharmaceuticals (BI | ||||
Conference: 33rd International Conference of Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Mental health, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
The Academy of Managed Care Pharmacy® NEXUS; Dallas, TX |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2017 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Phillips S, Johnson KJ, Shen SW, Woodcroft KJ, Oliveria SA, Simon TA | ||||
Phillips S: IQVIA; Johnson KJ: IQVIA (formerly); Shen SW: Bristol-Meyers Squibb; Woodcroft KJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol Meyers Squibb | ||||
American College of Rheumatology Annual Meeting, 3-8 November 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Patient Registries & Real-World Study Methods, Pregnancy | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
The fast route to evidence development for value in healthcare | ||||
Dreyer NA1, Rodriguez AM2. | ||||
a Quintiles Real-World & Late-Phase Research , Cambridge MA , USA ; 2b Quintiles Real-World & Late-Phase Research , Madrid Spain. | ||||
Current Medical Research and Opinion, in press. August 19, 2016 DOI: 10.1080/03007995.2016.1203768 |
||||
, Article | ||||
Abstract: http://www.tandfonline.com/doi/full/10.1080/03007995.2016.1203768 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Improving the Quality of Patient Outcomes By Increasing Data Harmonization – Lessons Learned from the Outcome Measures Framework (OMF) | ||||
Bibeau K. | ||||
Quintiles Real-World & Late-Phase Research | ||||
AcademyHealth Annual Reasearch Meeting, 26-28 June 2016, Boston |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | English | , Methodology, RWLPR (Real-World Late Phase Research-quintiles | |
Observational Research: Choosing the right research approach for the right question | ||||
Parmenter L. | ||||
Quintiles Real-World & Late-Phase Research | ||||
Pharmaceutical Commerce. Feb 2016. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Using enriched real-world research for deeper insights | ||||
Mack CD, Parmenter L, Brinkley E, Liu L, Dreyer NA | ||||
Chinese J Pharmacoepidemiology 2016; 25:27-37 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | Chinese | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Dynamic Real World Data Platform Integrating Automated Claims and Registry Data for Pharmacoepidemiologic Studies | ||||
Syd Phillips, Andre B. Araujo, Chrissa Proctor, William N. Malatestinic, Cynthia J. Larmore, Leslie R. Harrold, George W. Reed, Deb Casso, Karin Johnson, Jeremy Stamer, Susan A. Oliveria | ||||
S. Phillips, C. Proctor, D. Casso, J. Stamer, and S.A. Oliveria are employees of QuintilesIMS (formerly IMS Health) KJ was an employee of QuintilesIMS at the time of the study. A. B. Araujo, W. N. Malatestinic, and C. J. Larmore are employees and stock owners of Eli Lilly and Company. | ||||
International Conference on Pharmacoepidemiology and Therapeutic Risk Management. August 25-28; Dublin, Ireland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Review | |
Assessing Data Availability for Pharmacoepidemiology Research in 3 US Healthcare Databases Using the OMOP Common Data Model | ||||
Karin Johnson, Deb Casso, Amanda Anderson, Syd Phillips, Christian Reich, Urvi Shah, Mui van Zandt, Susan A. Oliveria | ||||
QuintilesIMS | ||||
OHDSI Symposium, Washington DC, September 23, 2016 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | English | , Database Study | |
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis | ||||
Risson V, Ghodge B, Bonzani IC, Korn JR, Medin J, Saraykar T, Sengupta S, Saini D, Olson M. | ||||
Novartis Pharma AG, Basel, Switzerland QuintileIMS | ||||
J Med Internet Res. 2016 Sep 22;18(9):e249 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Patient Registries & Real-World Study Methods | 2016 | English | , Data linkage, direct to patient research, Methodology, social media | |
Comparative Assessment of US Healthcare Databases and Linkage Capabilities for Pharmacoepidemiology Studies | ||||
Casso D, Johnson K, Phillips S, Anderson A, Oliveria SA. | ||||
Casso D: IQVIA; Johnson K: IQVIA (formerly), Phillips S: IQVIA; Anderson A: IQVIA; Oliveria SA: IQVIA | ||||
2016 International Conference on Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Database Study, Review | |
Evaluation of a Composite Endpoint for Measuring Neonatal Benefit in Clinical Trials of Tocolytics Using Electronic Medical Records (EMRs). | ||||
Pimenta JM, Brinkley E, Beach KJ, Montague TH, Mack CD | ||||
Quintiles Real-World & Late-Phase Research | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):133 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Methodology, RWLPR (Real-World Late Phase Research-quintiles | |
PROTECT: The Challenges and Successes | ||||
Reynolds R, Kurz X, Blackburn SCF. | ||||
Quintiles Real-World & Late-Phase Research | ||||
Drug Saf 2015; 24(S1):240. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Methodology, Review | |
Direct-to-patient Research: The Future of Pharmacovigilance? | ||||
Dreyer NA, Mt. Isa S, Richardson JL, Laursen M, Zetstra-van der Woude P, Jamry-Dziurla A, Hliva V, Bourke A, Blackburn S. | ||||
Direct-to-patient Research: The Future of Pharmacovigilance? | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):268. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , direct-to-patient research | |
Comparing Patient-centered Outcomes after Uterus-conserving Procedures for Uterine Fibroids Using a Linked Electronic Medical Record (EMR)-Claims Database. | ||||
Franke KM, Mendelsohn AB, Brinkley E, Velentgas P, Wang T, Myers ER, Lang K. | ||||
6Quintiles Real-World and Late Phase Researc | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):357. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Womens Health | 2015 | English | , Retrospective database analysis, RWLPR (Real-World Late Phase Research-quintiles | |
Registry of Patient Registries (RoPR): Pilot Results and Lessons Learned for Registering Observational Studies. | ||||
Leavy M, Campion D, Taylor T, Karl J | ||||
6Quintiles Real-World and Late Phase Research, | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):361 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Getting the Right Cohort: Effect of Inclusion Criteria in Studies Using EMR and Claims. | ||||
Brinkley E, Mack C, Wang T, Lang K. | ||||
Quintiles Real-World and Late Phase Research | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):512. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Hybrid prospective studies: Combining existing and new data sources to achieve research goals. | ||||
Mack CD, McNeill AM, Parmenter L, Davis K, Dreyer NA. | ||||
Quintiles Real-World and Late Phase Research | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1): 544. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Statistical Considerations for Handling Treatment Switches in Observational Studies | ||||
Hawkes W, Su Z, Mack CD, Bookwalter D, Velentgas P. | ||||
Quintiles Real-World and Late Phase Research | ||||
FDA-Industry Workshop 2015 Roundtable. Sept. 17, 2015. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Fifth interim analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER): Insights into management/practice in patients with PKU. | ||||
Lagler FB, Muntau AC, Feillet F, Rogoff D, Moreau-Stucker F, Alm J, Burlina A, Trefz FK. | ||||
Quintiles Real-World and Late Phase Research | ||||
Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Congress, 1–4 September 2015, Lyon, France, Abstract No. P-160 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare disease | 2015 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Evaluation of a new composite endpoint for measuring neonatal benefit in tocolytic clinical trials using electronic medical records (EMR) | ||||
Pimenta JM, Brinkley E, Beach KJ, Montague TH, Mack CD (presenter). | ||||
Quintiles Real-World and Late Phase Research | ||||
31st International Society of Pharmacoepidemiology, Boston MA. Aug 22-26, 2015. |
||||
, Podium presentation | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Franke KM, Mendelsohn AB, Brinkley E, Velentgas P, Myers ER, Lang K. | ||||
Comparing Patient-Centered Outcomes After Uterus-Conserving Procedures for Uterine Fibroids Using a Linked Electronic Medical Record (EMR)-Claims Database | ||||
Quintiles Real-World and Late Phase Research | ||||
31st International Society of Pharmacoepidemiology, Boston MA. Aug 22-26, 2015. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | ||
Improving Utility of Electronic Health Data for Clinical Research: The Need for Harmonization. | ||||
Leavy M, Barboza M, Rodriguez E, Rosenblum S, Green L. | ||||
Quintiles Real-World and Late Phase Research | ||||
31st International Society of Pharmacoepidemiology, Boston MA, Aug 22-26, 2015 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Registry of Patient Registries (RoPR): Pilot Results and Lessons Learned for Registering Observational Studies. | ||||
Leavy M, Taylor T, Karl J, Campion D, Barboza M. | ||||
International Society of Pharmacoepidemiology, Boston MA. Aug 22-26, 2015 International Society of Pharmacoepidemiology, Boston MA. Aug 22-26, 2015 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Successes and challenges of collecting data from consumers as part of a public private consortium | ||||
Reynolds R, Kurz X, Blackburn SCF | ||||
Quintiles Real-World and Late Phase Research | ||||
31st International Society of Pharmacoepidemiology, Boston MA. Aug 22-26, 2015. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry. | ||||
Toomey K, Gasparetto C, Shah JJ, Abonour R, Mehta J, Narang M, Terebelo HR, Hardin JW, Srinivasan S, Larkins G, Ricafort RJ, Nagarwala YM, Rifkin RM | ||||
2015 ASCO Annual Meeting. May 31-June 2, 2015 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
The Kuvan® Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to Sapropterin. | ||||
Trefz FK1, Muntau AC, Lagler FB, Moreau F, Alm J, Burlina A, Rutsch F, Bélanger-Quintana A, Feillet F; KAMPER investigators. | ||||
.1Department of Pediatrics, University of Heidelberg, Heidelberg, Germany, friedrich.trefz@gmx.de. | ||||
JIMD Rep. 2015;23:35-43 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , Observational study, RWLPR (Real-World Late Phase Research-quintiles | |
Balancing the interests of patient data protection and medication safety monitoring in a public-private partnership. | ||||
Dreyer NA1, Blackburn S, Hliva V, Mt-Isa S, Richardson J, Jamry-Dziurla A, Bourke A, Johnson R. | ||||
1Quintiles Real-World & Late-Phase Research, Scientific Affairs, Cambridge, MA, United States. | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | English | , direct to patient research, Review, RWLPR (Real-World Late Phase Research-quintiles | |
Prevention, examination and treatment of missing data in nonexperimental pharmacoepidemiologic studies. | ||||
Mack CD, Su Z, Mendelsohn AB, Dreyer NA | ||||
Quintiles Real-World and Late Phase Research | ||||
Chinese J Pharmacoepidemiology 2015; 24(1): 14-22 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2015 | Chinese | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Registries for Evaluating Patient Outcomes: A User’s Guide. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1.) | ||||
Gliklich RE, Dreyer NA, Levy M (eds). | ||||
AHRQ Publication No. 07-EHC001-1. Rockville, MD: Agency for Healthcare Research and Quality. Third edition, April, 2014. |
||||
, Book | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2014 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Characterization of missing data in clinical registry studies. | ||||
Mendelsohn AB, Dreyer NA, Mattox PW, Su Z, Swenson A, Li R, Turner JR, Velentgas P | ||||
Therapeutic Innovation & Regulatory Science 2014; 48(5): 574-582 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2014 | English | , Methodology, Review | |
Using real-world evidence to inform decision making. | ||||
Mack CD, Dreyer NA, Bosco J, Fabre A. | ||||
Chinese J Pharmacoepidemiology |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2014 | Chinese | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
A guide to guidelines. A symposium sponsored by the public policy committee | ||||
Hallas J, Rothman KJ, Kubota K, Blackburn S, Navarro AA, Dal Pan G. | ||||
Pharmacoepidemiology and Drug Safety. 2014; 23:40. |
||||
, Newsletter | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Nesting Studies within Patient Registries | ||||
Gliklich, RE, Dreyer NA, Leavy MB, Khurana L, Mattox P, Berliner E, Kremer JM, Pappa D.. | ||||
AcademyHealth Annual Research Meeting. June 2013. Baltimore, Maryland |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
A Decision Aid for Initiating a Registry Study | ||||
Velentgas P, Bosco JL, Bryant A, Arcona S, Kahler K, Dreyer NA,. | ||||
Quintiles Real-World & Late-Phase Research | ||||
29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, August 2013. |
||||
, Podium presentation | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, Review | |
Econometric methods for assessing treatment-effect heterogeneity | ||||
Basu A, Vanness D, Stull D, Thompson D. | ||||
quintiles real world and late phase reserach | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013 |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Are administrative claims becoming obsolete? | ||||
Berger M, Thompson D, Crown, WH | ||||
quintiles real world and late-phase research | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013. |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Expanding the evidence base in outcomes research: using linked electronic medical records (EMR) and claims data | ||||
Huse DM, Russo PA, Vasey J, Durden E. | ||||
Quintiles real world & late phase research | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013. |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Challenges in developing an outcome measures framework for patient registries. | ||||
Gliklich R, Karl J, Leavy MB, Khurana L, Campion DM, Taylor T, Levy D, Berliner E, Hossfeld W. | ||||
quintiles Real world & late-phase research | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Registry of patient registries (ROPR): Purpose, design and early experience | ||||
Gliklich R, Levy D, Campion DM, Leavy MB, Taylor T, Karl J, Berliner E, Khurana L, Hossfeld W | ||||
Quintiles real world & late phase research | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Extension of the Hosmer-Lemeshow goodness of fit statistic to linear models with repeated measurements. | ||||
Li R, Su Z; Mendelsohn A, Gemmen E. | ||||
Quintiles Real-World and Late Phase Research | ||||
ISPOR 18th Annual Meeting, New Orleans, LA, May 2013 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Methodology, RWLPR (Real-World Late Phase Research-quintiles | |
Considerations for Creating a Calendar Time Instrumental Variable | ||||
Mack CD, Brookhart MA, Glynn RJ, Stürmer T. | ||||
Quintiles Real world & Late phase research | ||||
29th ICPE: International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, August 15-28, 2013 |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2013 | English | , Methodology, RWLPR (Real-World Late Phase Research-quintiles | |
Studies to inform decision-making: the need for a two-phase approach to assessing quality and appropriateness. | ||||
Dreyer N, Leavy MB, Velentgas P. | ||||
Quintiles Real world & Late phase research | ||||
ISPOR 5th Asia-Pacific Conference, September 2012, Taipei, Taiwan. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Latent transition analysis as a tool for analysing clinical data | ||||
Mayer D, Burgess AJ. | ||||
Quintiles Real world & Late phase research | ||||
ISPOR 5th Asia-Pacific Conference, 2September 2012, Taipei, Taiwan. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Methodology, RWLPR (Real-World Late Phase Research-quintiles | |
The organizational structure and governing principles of the Food and Drug Administration’s Mini-Sentinel pilot program. | ||||
Forrow S, Campion DM, Herrinton LJ, Nair VP, Wilson M, Platt R. | ||||
Quintiles real world & late phase research | ||||
Pharmacoepidemiol Drug Saf 2012 Jan; 21(Suppl 1):12-17. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
International collaboration in the use of registries for new devices and procedures | ||||
REGISTER Group (Campbell B , Patrick H, Dreyer NA, Grilli R, Franklin GM, Lee Robin SH, Maddern G, Tunis S, Lyratzopoulos G). | ||||
1National Institute for Health and Clinical Excellence, 71 High Holborn, London WC1V 6NA, UK. | ||||
Brit J Surg 2012; 99: 744–745. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force. | ||||
Gliklich R, Glennie J, Mattox PW, Graff JS, Garner S, Marrone CM, Shaya FT, Hansen J, Lewin J, Blackburn S, Berger M, Dreyer NA. | ||||
Drug Information J 2012; 26:185-191 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles, Survey research | |
Registries. | ||||
Dreyer NA, Velentgas P | ||||
Quintiles Real-World and Late Phase Research | ||||
Pharmacoepidemiology, Strom B, Kimmel S, Hennessy S, Eds. Fifth edition, John Wiley & Sons, Ltd. 2012 |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
New pharmacovigilance legislation: A call to ARMS to the pharmacoepidemiology community. | ||||
Blackburn SCF, Arlett PR, Evans SJ, Perez-Gutthann S | ||||
Quintiles real world & late phase research | ||||
Pharmacoepidemiol Drug Saf. 2012;21(Supp 3):S339. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2012 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Increasing scientific standards, Transparency and independence in pharmacoepidemiological research: Is the concept of ENCePP studies a way forward? | ||||
Kurz X, Leufkens B, Blackburn S1, Moride Y, Simmons V, De Vries C | ||||
1-Quintiles Real world & Late phase Research | ||||
Pharmacoepidemiology and Drug Saf. 2011; 20:S150 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2011 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Generating evidence for decision making | ||||
Dreyer, N. | ||||
quintiles real world & late phase research | ||||
Am J Epidemiol 2010; 171(Suppl):S158-S165). |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2010 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
How can better scientific methods result in better drug regulation-two recent case studies. | ||||
De Bruin ML, Blackburn S, Persson I, Rassen J, Grimaldi L. | ||||
Quintiles real world & late phase research | ||||
Pharmacoepidemiology and Drug Saf. 2010;19:S135-S6 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2010 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
The alternate life of regulators | ||||
Blackburn SCF, Arlett P, Kurz X, Fitt H. | ||||
quintiles real world & late phase research | ||||
Pharmacoepidemiology and Drug Saf. 2010;19:S243-S4 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2010 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Registries for robust evidence. | ||||
Dreyer NA, Garner S. | ||||
quintiles real world & late phase research | ||||
JAMA. 2009 Aug 19;302(7):790-1 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2009 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Patient registries, predictive models and optimal care (letter). | ||||
Dreyer NA, Garner S | ||||
quintiles real world & late phase research | ||||
JAMA 2009; 302(24):2662 |
||||
, Letter | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2009 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Can registries deliver? The methods and use of registries for biologics. | ||||
Zhao S, Dreyer NA, Cole A,Stemhagen A, Feltelius N, Haas J. | ||||
quintiles real world and late phase research | ||||
Pharmacoepidemiol Drug Saf 2009; 18:S27. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2009 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
The challenges of epidemiology | ||||
Saddier P, Perez-Gutthann S, Stemhagen A, Garg R, Blackburn S, Dal Pan G. RMP, RiskMAP and REMS | ||||
quintiles real world & late phase research | ||||
Pharmacoepidemiology and Drug Saf. 2009;18(S1):S203-S4 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2009 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Proactive planning in pharmacovigilance | ||||
Cappe S, Blackburn S, Brosch S, Tsintis P | ||||
Quintiles real world & late phase research | ||||
Good Clinical Practice Journal. 2006;13(6):14-7 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2006 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |